Salvia przewalskii (Salvia przewalskii): Benefits, Dosage, Safety & Evidence

Frequently asked questions

How does Salvia przewalskii work to support cardiovascular health?

Salvia przewalskii contains bioactive compounds including tanshinones and salvianolic acids that may support cardiovascular function through antioxidant and anti-inflammatory mechanisms. These compounds appear to help protect blood vessel walls, improve circulation, and may inhibit platelet aggregation. The herb has traditionally been used to invigorate blood flow in Chinese medicine. Current evidence is limited primarily to laboratory and animal studies (Evidence Level C), with more human clinical research needed to fully establish its mechanism of action.

Can I take Salvia przewalskii with blood thinners or anticoagulants?

No, Salvia przewalskii should not be combined with blood-thinning medications. The herb contains compounds that affect platelet function and blood clotting, which can increase bleeding risk when taken with anticoagulants like warfarin, aspirin, clopidogrel, or similar medications. This interaction is well-recognized in traditional Chinese medicine practice. Combining this herb with blood thinners could lead to serious bleeding complications. Always consult a healthcare provider before adding herbal supplements to any anticoagulant regimen.

What is the recommended dosage for Salvia przewalskii?

Traditional dosage recommendations for Salvia przewalskii include 5-10 grams of dried herb daily when prepared as tea or decoction. For liquid tincture preparations, the typical adult dosage is 2-4 milliliters taken three times per day. These recommendations are based on traditional use and practitioner experience rather than standardized clinical trials (Evidence Level C). Appropriate dosage may vary based on individual health status and specific formulations. Consult a qualified herbalist or healthcare provider for personalized dosing guidance.

Is Salvia przewalskii safe to take during pregnancy?

Salvia przewalskii is considered unsafe during pregnancy and should be avoided. The herb contains tanshinones and other compounds that may stimulate uterine contractions and increase bleeding risk, both of which could endanger the pregnancy. Traditional Chinese medicine explicitly contraindicates this herb for pregnant women. There is insufficient safety data for use during breastfeeding, so avoidance is recommended for nursing mothers as well. Pregnant women should consult their healthcare provider before using any herbal supplements.

What is Salvia przewalskii used for in traditional Chinese medicine?

Salvia przewalskii has been used traditionally in Chinese and Tibetan medicine for promoting blood circulation and supporting cardiovascular health. Practitioners have historically used this herb for heart conditions, chest pain, and menstrual discomfort due to its believed ability to invigorate blood flow and relieve stagnation. The herb is also valued for its analgesic and anti-inflammatory properties. Native to Yunnan and Sichuan provinces, it is closely related to Dan Shen (Salvia miltiorrhiza) and shares similar therapeutic applications (Evidence Level C).

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Salvia przewalskii is a perennial plant of the Lamiaceae family used in traditional Chinese medicine, primarily for treating cardiovascular and blood circulation-related illnesses [PMID:34834049, PMID:29025319].

Background

Salvia przewalskii Maxim is a perennial herb from the genus Salvia (family Lamiaceae) [PMID:34834049, PMID:35588305]. It is often used as a surrogate for Salvia miltiorrhiza (Danshen) in western areas of mainland China [PMID:18855446, PMID:29105962].

Traditional uses

The roots have been long used as a traditional herb in China to treat blood circulation-related illnesses and cardiovascular diseases [PMID:34834049, PMID:29025319, PMID:41241801].

Active compounds

Active components include phenolic acids (rosmarinic acid, salvianolic acid B, caffeic acid, sodium danshensu, lithospermic acid) [PMID:31875579, PMID:29105962], tanshinones (tanshinone IIA, cryptotanshinone, dihydrotanshinone I), and various diterpenoids such as Przewaquinone A, Przewalskin A, and Salprzesides A and B [PMID:31875579, PMID:39096544, PMID:29191008, PMID:33843371].

Mechanism of action

Przewaquinone A inhibits vascular contraction and endothelial diastolic dysfunction via activation of AMPK [PMID:39096544]. It also acts as a STAT3 inhibitor to suppress melanoma cell growth and induce autophagy [PMID:40311593]. Total phenolic acid extracts (SPE) inhibit TLR4 signaling activation in podocytes [PMID:29619899] and may exert anti-hypoxic effects through the RhoA-ROCK signaling pathway [PMID:31875579].

Clinical evidence

Evidence DEndothelial Dysfunction

Przewaquinone A inhibits Angiotensin II-induced endothelial diastolic dysfunction [PMID:39096544]

Evidence DMelanoma

Przewaquinone A suppresses the growth and metastasis of melanoma cells [PMID:40311593]

Evidence DImmune Complex Glomerulonephritis (Rats)

Total phenolic acid extract (SPE) significantly reduced urine protein excretion [PMID:29025319]

Evidence DPodocyte Injury (Rats/In Vitro)

High-dose SPE significantly decreased proteinuria and alleviated F-actin stress fiber disruption [PMID:26439819, PMID:29619899]

Evidence DAcute Spinal Cord Injury (Rats)

SPE enhanced BBB scores, improved inclined plane angles, and reduced inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-17, IL-18) [PMID:41241801]

Evidence DHigh-Altitude Pulmonary Hypertension (Rats)

Extracts showed anti-hypoxic effects, including prolonged survival time in acute hypoxic preconditioning [PMID:31875579, PMID:32239860, PMID:32476549]

Safety & adverse effects

In a rat model of acute spinal cord injury, SPE did not have significant adverse effects on body mass on day 1 and 3 after administration [PMID:41241801].

Evidence summary

The current evidence is based primarily on in vitro studies and animal models (rats and mice), indicating potential anti-inflammatory, neuroprotective, and cardiovascular benefits. No human clinical trials were provided.

PubMed sources

1.PMID: 39096544 (2024) — Przewaquinone A inhibits Angiotensin II-induced endothelial diastolic dysfunction activation of AMPK. · Phytomedicine : international journal of phytotherapy and phytopharmacology
2.PMID: 40311593 (2025) — Przewaquinone A, as a natural STAT3 inhibitor, suppresses the growth of melanoma cells and induces autophagy. · Phytomedicine : international journal of phytotherapy and phytopharmacology
3.PMID: 29191008 (2018) — Biomimetic Synthesis of Isorosmanol and Przewalskin A. · The Journal of organic chemistry
4.PMID: 34834049 (2021) — Regioisomers Salviprolin A and B, Unprecedented Rosmarinic Acid Conjugated Dinorditerpenoids from Salvia przewalskii Maxim. · Molecules (Basel, Switzerland)
5.PMID: 39195537 (2024) — Content Determination and Chemical Clustering Analysis of Tanshinone and Salvianolic Acid in Salvia spp.

Salvia przewalskii

Sources & Citations

Calculate a safe dose of Salvia przewalskii